Hepatocyte induced re-expression of E-cadherin in breast and prostate cancer cells increases chemoresistance

Clinical and Experimental Metastasis

Volumn 29, Issue 1, 2012, Pages 39-50

  Chao, Yvonne ^a   Wu, Qian ^a   Shepard, Christopher ^a   Wells, Alan ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Cell death; Chemoresistance; Epithelial to mesenchymal transition; Mesenchymal to epithelial reverting transition

Indexed keywords

UVOMORULIN; CADHERIN;

ANIMAL CELL; ARTICLE; BREAST CANCER; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIVER CELL; METASTASIS; NONHUMAN; PROSTATE CANCER; PROTEIN EXPRESSION; RAT; BREAST TUMOR; CELL ADHESION; DRUG RESISTANCE; FEMALE; MALE; METABOLISM; PROSTATE TUMOR; TUMOR CELL LINE;

BREAST NEOPLASMS; CADHERINS; CELL ADHESION; CELL LINE, TUMOR; CELL SURVIVAL; DRUG RESISTANCE, NEOPLASM; FEMALE; HEPATOCYTES; HUMANS; MALE; PROSTATIC NEOPLASMS;

EID: 84856013044     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-011-9427-3     Document Type: Article

References (41)

1. Viadana E, Bross ID, Pickren JW (1973) An autopsy study of some routes of dissemination of cancer of the breast. Br J Cancer 27(4):336-340
2. Lermite E, Marzano E, Chereau E et al (2010) Surgical resection of liver metastases from breast cancer. Surg Oncol 19(4):e79-e84
3. Atalay G, Biganzoli L, Renard F et al (2003) Clinical outcome of breast cancer patients with liver metastases alone in the anthracycline-taxane era: a retrospective analysis of two prospective, randomised metastatic breast cancer trials. Eur J Cancer 39(17):2439-2449 (Pubitemid 37340158)
4. Diamond JR, Finlayson CA, Borges VF (2009) Hepatic complications of breast cancer. Lancet Oncol 10(6):615-621
5. Wells A, Chao Y, Wu Q (2011) Biology of metastatic liver tumors. In: Monga SPS (ed) Molecular pathology of liver diseases. Springer, New York, pp 859-866
6. Viadana E, Cotter R, Pickren JW et al (1973) An autopsy study of metastatic sites of breast cancer. Cancer Res 33(1):179-181
7. Gassmann P, Hemping-Bovenkerk A, Mees ST et al (2009) Metastatic tumor cell arrest in the liver-lumen occlusion and specific adhesion are not exclusive. Int J Colorectal Dis 24(7): 851-858
8. Glinskii OV, Huxley VH, Glinsky GV et al (2005) Mechanical entrapment is insufficient and intercellular adhesion is essential for metastatic cell arrest in distant organs. Neoplasia 7(5): 522-527 (Pubitemid 40791870)
9. McGuire EJ, Mascali JJ, Grady SR et al (1984) Involvement of cell-cell adhesion molecules in liver colonization by metastatic murine lymphoma/lymphosarcoma variants. Clin Exp Metastasis 2(3):213-222 (Pubitemid 15178623)
10. Tabaries S, Dong Z, Annis MG et al (2011) Claudin-2 is selectively enriched in and promotes the formation of breast cancer liver metastases through engagement of integrin complexes. Oncogene 30(11):1318-1328
11. Mannori G, Crottet P, Cecconi O et al (1995) Differential colon cancer cell adhesion to E-, P-, and L-selectin: role of mucin-type glycoproteins. Cancer Res 55(19):4425-4431
12. Paschos KA, Canovas D, Bird NC (2009) The role of cell adhesion molecules in the progression of colorectal cancer and the development of liver metastasis. Cell Signal 21(5):665-674
13. Lou Y, Preobrazhenska O, auf dem Keller U et al (2008) Epithelial-mesenchymal transition (EMT) is not sufficient for spontaneous murine breast cancer metastasis. Dev Dyn 237(10): 2755-2768
14. Aslakson CJ, Miller FR (1992) Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res 52(6): 1399-1405
15. Luebke-Wheeler JL, Nedredal G, Yee L et al (2009) E-cadherin protects primary hepatocyte spheroids from cell death by a caspase-independent mechanism. Cell Transplant 18(12):1281-1287
16. Lugo-Martinez VH, Petit CS, Fouquet S et al (2009) Epidermal growth factor receptor is involved in enterocyte anoikis through the dismantling of E-cadherin-mediated junctions. Am J Physiol Gastrointest Liver Physiol 296(2):G235-G244
17. Pece S, Chiariello M, Murga C et al (1999) Activation of the protein kinase Akt/PKB by the formation of E-cadherin-mediated cell-cell junctions. Evidence for the association of phosphatidylinositol 3-kinase with the E-cadherin adhesion complex. J Biol Chem 274(27):19347-19351
18. Pece S, Gutkind JS (2000) Signaling from E-cadherins to the MAPK pathway by the recruitment and activation of epidermal growth factor receptors upon cell-cell contact formation. J Biol Chem 275(52):41227-41233 (Pubitemid 32054955)
19. Carmeliet P, Lampugnani MG, Moons L et al (1999) Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell 98(2):147-157 (Pubitemid 29344903)
20. Yates CC, Shepard CR, Stolz DB et al (2007) Co-culturing human prostate carcinoma cells with hepatocytes leads to increased expression of E-cadherin. Br J Cancer 96(8):1246-1252 (Pubitemid 46625074)
21. Chao YL, Shepard CR, Wells A (2010) Breast carcinoma cells reexpress E-cadherin during mesenchymal to epithelial reverting transition. Mol Cancer 9:179
22. Li M, Aliotta JM, Asara JM et al (2010) Intercellular transfer of proteins as identified by stable isotope labeling of amino acids in cell culture. J Biol Chem 285(9):6285-6297
23. St Croix B, Kerbel RS (1997) Cell adhesion and drug resistance in cancer. Curr Opin Oncol 9(6):549-556 (Pubitemid 27480858)
24. Green SK, Francia G, Isidoro C et al (2004) Antiadhesive antibodies targeting E-cadherin sensitize multicellular tumor spheroids to chemotherapy in vitro. Mol Cancer Ther 3(2):149-159 (Pubitemid 39193689)
25. Wang L, Li Z, Wang C et al (2009) E-cadherin decreased human breast cancer cells sensitivity to staurosporine by up-regulating Bcl-2 expression. Arch Biochem Biophys 481(1):116-122
26. Yates C, Wells A, Turner T (2005) Luteinising hormone-releasing hormone analogue reverses the cell adhesion profile of EGFR overexpressing DU-145 human prostate carcinoma subline. Br J Cancer 92(2):366-375 (Pubitemid 40343154)
27. Guriec N, Marcellin L, Gairard B et al (1996) E-cadherin mRNA expression in breast carcinomas correlates with overall and disease-free survival. Invasion Metastasis 16(1):19-26 (Pubitemid 26308409)
28. Brown LA, Arterburn LM, Miller AP et al (2003) Maintenance of liver functions in rat hepatocytes cultured as spheroids in a rotating wall vessel. In Vitro Cell Dev Biol Anim 39(1-2):13-20 (Pubitemid 36944604)
29. Dash A, Inman W, Hoffmaster K et al (2009) Liver tissue engineering in the evaluation of drug safety. Expert Opin Drug Metab Toxicol 5(10):1159-1174
30. Powers MJ, Domansky K, Kaazempur-Mofrad MR et al (2002) A microfabricated array bioreactor for perfused 3D liver culture. Biotechnol Bioeng 78(3):257-269 (Pubitemid 34712370)
31. Gassmann P, Haier J (2008) The tumor cell-host organ interface in the early onset of metastatic organ colonisation. Clin Exp Metastasis 25(2):171-181
32. Chao YL, Wu Q, Acquafondata M et al (2011) Partial mesenchymal to epithelial reverting transition in breast and prostate cancer metastases [abstract nr. 3357]. In: Proceedings of the 102nd annual meeting of the American Association for Cancer Research. Orlando, FL, Philadelphia (PA): AACR
33. Bergin E, Levine JS, Koh JS et al (2000) Mouse proximal tubular cell-cell adhesion inhibits apoptosis by a cadherin-dependent mechanism. Am J Physiol Renal Physiol 278(5):F758-F768 (Pubitemid 30351077)
34. Langley RR, Fan D, Guo L et al (2009) Generation of an immortalized astrocyte cell line from H-2Kb-tsA58 mice to study the role of astrocytes in brain metastasis. Int J Oncol 35(4): 665-672
35. Lin Q, Balasubramanian K, Fan D et al (2010) Reactive astrocytes protect melanoma cells from chemotherapy by sequestering intracellular calcium through gap junction communication channels. Neoplasia 12(9):748-754
36. West KA, Castillo SS, Dennis PA (2002) Activation of the PI3K/Akt pathway and chemotherapeutic resistance. Drug Resist Updat 5(6):234-248 (Pubitemid 36132805)
37. St Croix B, Florenes VA, Rak JW et al (1996) Impact of the cyclin-dependent kinase inhibitor p27Kip1 on resistance of tumor cells to anticancer agents. Nat Med 2(11):1204-1210 (Pubitemid 26375403)
38. St Croix B, Sheehan C, Rak JW et al (1998) E-Cadherindependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27 (KIP1). J Cell Biol 142(2):557-571 (Pubitemid 28361560)
39. Li Z, Zhou Z, Donahue HJ (2008) Alterations in Cx43 and OBcadherin affect breast cancer cell metastatic potential. Clin Exp Metastasis 25(3):265-272
40. Chu K, Cheng CJ, Ye X et al (2008) Cadherin-11 promotes the metastasis of prostate cancer cells to bone. Mol Cancer Res 6(8):1259-1267
41. Tsuji T, Ibaragi S, Hu GF (2009) Epithelial-mesenchymal transition and cell cooperativity in metastasis. Cancer Res 69(18):7135-7139